Australia markets closed

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.47+0.02 (+0.27%)
At close: 04:00PM EDT
7.63 +0.16 (+2.14%)
After hours: 07:15PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 476.79M
Enterprise value 842.86M
Trailing P/E N/A
Forward P/E 26.67
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.90
Price/book (mrq)2.78
Enterprise value/revenue 1.61
Enterprise value/EBITDA 12.40

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3106.35%
S&P500 52-week change 318.96%
52-week high 37.76
52-week low 32.82
50-day moving average 36.45
200-day moving average 35.01

Share statistics

Avg vol (3-month) 3516.28k
Avg vol (10-day) 3332.27k
Shares outstanding 563.83M
Implied shares outstanding 663.83M
Float 826.72M
% held by insiders 111.41%
% held by institutions 160.01%
Shares short (15 July 2024) 41.63M
Short ratio (15 July 2024) 42.01
Short % of float (15 July 2024) 43.76%
Short % of shares outstanding (15 July 2024) 42.56%
Shares short (prior month 14 June 2024) 4567.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin -4.14%
Operating margin (ttm)4.34%

Management effectiveness

Return on assets (ttm)1.52%
Return on equity (ttm)-11.87%

Income statement

Revenue (ttm)522.74M
Revenue per share (ttm)8.30
Quarterly revenue growth (yoy)8.70%
Gross profit (ttm)N/A
EBITDA 42.62M
Net income avi to common (ttm)-21.65M
Diluted EPS (ttm)-0.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.17M
Total cash per share (mrq)0.39
Total debt (mrq)415.9M
Total debt/equity (mrq)191.28%
Current ratio (mrq)1.53
Book value per share (mrq)2.69

Cash flow statement

Operating cash flow (ttm)6.85M
Levered free cash flow (ttm)17.54M